Clinical trials
Completed Cholangiocarcinoma trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 2 |
| Symphogen A/S | 2 |
| AbbVie | 1 |
| Basilea Pharmaceutica | 1 |
| Bayer | 1 |
| Boston Scientific Corporation | 1 |
| Jazz Pharmaceuticals | 1 |
| Sumitomo Pharma America, Inc. | 1 |
| Taiho Oncology, Inc. | 1 |
| Zymeworks BC Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cholangiocarcinoma | 12 |
| Stomach Neoplasms | 6 |
| Esophageal Neoplasms | 4 |
| Neoplasms | 4 |
| Carcinoma, Hepatocellular | 3 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Colorectal Neoplasms | 3 |
| Ovarian Neoplasms | 3 |
| Triple Negative Breast Neoplasms | 3 |
| Bile Duct Neoplasms | 2 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.